Maruti Suzuki cars to become 4% more expensive starting April 2025
Maruti Suzuki, Hyundai Motor India, Mahindra & Mahindra (M&M), and JSW MG Motor all announced price hikes this year to offset ...
Dyne announces new long-term data from Phase 1/2 DELIVER trial of DYNE-251
Dyne Therapeutics (DYN) announced new long-term clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 demonstrating unprecedented ...
Sutro Biopharma presents expanded data from REFRalphaME-01 trial
Sutro Biopharma (STRO) announced expanded data in a late-breaking oral presentation from the dose-optimization portion of the REFRalphaME-O1 ...
Le Lézard7 分钟
Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results
Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...
MIT Technology Review18 小时
Now read the rest of The Algorithm
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each ...